104 related articles for article (PubMed ID: 1374308)
1. Experimental and clinical evaluation by flow cytometry for the mechanism of combination therapy (cisplatin and peplomycin).
Kawamoto K; Wada Y; Kumazawa H; Yamashita T; Kumazawa T; Matsumura H
Cytometry; 1992; 13(3):307-13. PubMed ID: 1374308
[TBL] [Abstract][Full Text] [Related]
2. [Experimental studies on combination chemotherapy of cisplatin with peplomycin against human squamous cell carcinomas in nude mice].
Ekimoto H; Aikawa M; Takahashi K; Matsuda A
Gan To Kagaku Ryoho; 1985 Jan; 12(1):70-6. PubMed ID: 2578275
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of cisplatin and peplomycin therapy on head and neck carcinoma].
Kumazawa H; Wada Y; Tachikawa T; Kakimoto S; Yamashita T; Kawamoto K
Hum Cell; 1996 Mar; 9(1):69-74. PubMed ID: 9183633
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation by flow cytometry in the mechanism of action of CDDP with arterial injection of bromo deoxyuridine].
Wada Y; Kawamoto K; Oka S; Kuriyama H; Yamashita T; Kumazawa T; Matsumura H
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2973-6. PubMed ID: 3662549
[No Abstract] [Full Text] [Related]
5. [Clinical study of combination chemotherapy with continuously infused peplomycin (PEP), cis-dichlorodiammineplatinum (II) (CDDP) and mitomycin C (MMC) (PPM therapy)].
Goto T; Furuta I; Urata A; Fukushima M; Okuma K; Oyama A; Murakami M; Ariyoshi Y; Nishimura M; Kurita S
Nihon Gan Chiryo Gakkai Shi; 1983 Dec; 18(8):2054-60. PubMed ID: 6201578
[No Abstract] [Full Text] [Related]
6. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation for the mechanism of cisplatin with bromodeoxyuridine by flow cytometry and clinico-histological study.
Wada Y; Kawamoto K; Oka S; Yamashita T; Kumazawa T; Matsumura H
Life Sci; 1989; 44(4):259-64. PubMed ID: 2492628
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of advanced hypopharyngeal cancer with combination chemotherapy (VPCP regimen) followed by subsequent radiotherapy: a case report].
Kawaida M; Fukuda H; Kohno N; Fujii M; Tanaka J; Inuyama Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3787-90. PubMed ID: 2480749
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy of cisplatin, vincristine and peplomycin for patients with head and neck carcinoma].
Tsukuda M; Tamamushi N; Mochimatsu I; Nakagawa C; Furukawa M; Kubota A; Hiiragi K; Nishimoto Y; Mitarai K; Oishi K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):486-90. PubMed ID: 2420278
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
11. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
Yamauchi T; Okada K; Yoshida O
Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
[TBL] [Abstract][Full Text] [Related]
12. [Experimental studies on combination chemotherapy based on cell cycle analysis].
Tsuboi T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):629-36. PubMed ID: 2580923
[TBL] [Abstract][Full Text] [Related]
13. [Cytofluorometric chase of the cancer cells after release from G2-block induced by peplomycin].
Masugi M; Konishi E; Ueda K; Azumi Y; Ashihara T
Gan To Kagaku Ryoho; 1994 Apr; 21(5):683-8. PubMed ID: 8154893
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
Okada K; Kanamaru H; Yoshiki T; Hashimura T; Nishimura K; Hida S; Nishio Y; Oishi K; Yoshida O; Yamauchi T
Hinyokika Kiyo; 1988 Nov; 34(11):1911-6. PubMed ID: 2468265
[TBL] [Abstract][Full Text] [Related]
15. [Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
Sugasawa M; Nibu K; Ichimura K; Kaga K; Asai M; Senba T; Yamasoba T; Tsunoda K; Abe K; Kobayashi T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):969-74. PubMed ID: 8002635
[TBL] [Abstract][Full Text] [Related]
16. [Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
Yasui Y; Suzumori K; Asai H; Yagami Y
Gan No Rinsho; 1985 Sep; 31(11):1415-21. PubMed ID: 2415720
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between morphological manifestations and cell kinetic changes of human lung cancer cells after exposure to chemotherapeutic agents].
Ito M
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):718-36. PubMed ID: 2430876
[TBL] [Abstract][Full Text] [Related]
18. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study for combination therapy of cisplatin and peplomycin.
Fujii M; Inuyama Y; Tanaka J; Takaoka T; Hosoda H
Keio J Med; 1986 Oct; 35(4):267-75. PubMed ID: 2438446
[No Abstract] [Full Text] [Related]
20. [Clinical and histological effect of induction chemotherapy with peplomycin, vincristine, mitomycin C and cis-platinum on oral squamous cell carcinomas].
Shirasuna K; Ogura T; Mima T; Hiranuma T; Sakai T; Hayashido Y; Matsuya T; Usui M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):53-8. PubMed ID: 7826078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
